The Canadian Fertility and Andrology Society invites you to participate in the scientific program by submitting an abstract to be considered for presentation.
DEADLINE FOR ABSTRACT SUBMISSIONS: Sunday, April 30th, 2017 23:59 EST
All abstracts must be submitted through the electronic online Abstract Submitter.
Please note submission procedure
- An CFAS Ethical Standards Disclosure for the presenter and EACH author must be enclosed with each abstract submitted
- NO abstracts submitted on paper will be accepted.
- NO faxed abstracts will be accepted.
- NO emailed abstracts will be accepted. (Do not email abstracts to the CFAS office.)
- NO ABSTRACTS REGARDING HUMAN REPRODUCTIVE CLONING WILL BE ACCEPTED.
Abstracts submitted must contain original work and must not have been published previously or presented at a meeting of another national or international scientific organization prior to this meeting.
All individuals who require a visa to enter Canada are urged to begin making travel arrangements and obtaining necessary papers now to attend the meeting. A letter confirming registration to the meeting may be obtained by request at firstname.lastname@example.org. The letter does not imply any financial support by CFAS.
All abstracts must be submitted through the electronic online Abstract Submitter. Please be sure to review the submission criteria before submitting your abstract. If you require more information please contact the CFAS Office:
Canadian Fertility & Andrology Society
1719 rue Grand Trunk, Suite 301
Montreal, QC H3K 1M1
Submission Deadline and Guidelines
All abstracts must be submitted via the Online Submission system no later than Sunday, April 30th, 2017 – 23:59 EST.
Abstracts should be submitted in English only.
The success of any scientific meeting depends upon the quality of not only its plenary lectures, but also the free communications contributed by the registrants. Consequently, much thought has been devoted to ensuring that our meeting will provide the best possible forum for registrants to present their new and exciting research and clinical results.
As with every meeting there is a finite amount of time that can be dedicated in the program for presentation of oral free communications and many registrants’ work has to be assigned to poster presentations. Abstracts will be subject to anonymous peer review by 3 or more referees and, in general, those with the highest scores will be assigned oral presentation format.
Other accepted abstracts will be assigned to poster format presentation. If you are not willing to accept either an oral or a poster format presentation, you must indicate this at the time of submission. For Poster presentation guidelines please click here.
Any topic relevant to human reproduction, assisted conception or reproductive genetics will be considered for inclusion in the meeting program. Abstracts must report results of a study or investigation. Any abstract not including adequate data, or saying that “results will be presented / discussed” will not be accepted. Appropriate statistical analysis of data must be presented.
Material submitted should not have been presented at a national or international meeting or published prior to our meeting.
By submitting an abstract, authors warrant that the work was conducted in complete accordance with any and all local, national and international ethical guidelines or regulations, including the Nuremberg Code and the Declaration of Helsinki.
- Use a structured layout for the abstract including headings (in bold): Introduction, Materials and Methods, Results, Discussion (or Conclusions), and References (if applicable).
- Authorship of abstracts should conform to international standards.
- The abstract should be typed single-spaced with one line of space between paragraphs and headings. Do not indent paragraphs.
- The body of the document should be no more than 375 words (2200 characters, including spaces).
- Please make sure that the abstract file document is in .doc or .docx format.
- Introduction – should be informative and short, stating why the study was conducted.
- Material & methods – indicating the locale, number and type of human subjects, non-human species or material being studied, the principal procedures, assays, tests or treatments performed.
- Results – confirming or refuting the hypothesis, supported by statistics if appropriate.
- Conclusions – stating the major new findings of the study and specifying what these findings add to what is known already.
- References – if applicable.
- Type the title in bold, authors in italics, and body in normal text.
- Do not use capital letters and do not indent.
- The title should reflect the contents and should be no longer than 150 characters.
- List all authors first name followed by family name followed by affiliation.
(i.e. 1 John Campbell, 2 Margaret Witherspoon;
1 University of Toronto, Ontario, Canada; 2 Fertility Clinic, Red Deer, Alberta, Canada)
- The name of the first author is also the presenting author.
- Do not include professional titles or degrees.
- Graphic elements such as tables and graphs should be included in your document. However, please DO NOT incorporate any large graphic elements, as this will limit the amount of words you may include.
- As a guide, all text and graphics must fit within a 7.5″ by 8″ box.
- Abbreviations, acronyms and units:
- Standard abbreviations and acronyms may be used without prior definition (e.g. IVF, OPU, GnRH, FSH, HSA, etc), but all non-standard terms must be defined where first used in the text.
- SI units should be used throughout.
- Identify significant differences using an italic capital letter “P”, e.g. P
Please check your abstract carefully; it will be published as submitted.
An Ethical Standards Disclosure Form for the presenter and EACH author must be completed for each submitted abstract.
All abstracts will be evaluated blindly by the Program Committee.
You will be notified by email by the end of May 2017 as to whether or not your abstract has been accepted for presentation and you will be provided with details regarding designation (i.e., oral or poster), classification, and time allocation.
Only registered meeting participants will be accepted as abstract presenters. Submission of an abstract indicates acceptance of and compliance with the abstract submission guidelines.
Abstract will NOT be included in the program unless the presenting author register for the meeting no later than June 15, 2017
HARD COPY ABSTRACTS (SENT BY FAX OR MAIL) WILL BE DISCARDED!!!
Please read the instructions carefully and follow the steps for submission. For each step, make sure that all required fields are completed before moving on to the next step.
The Effects of Canoeing and Consumption of River Water on Sperm Production in Males
Orlando Cantswim¹*, Stan Duppinbote², John Smith¹
¹College of Medical Nonsense, Halifax, Nova Scotia; ²Fictitious College, St. Johns, New Brunswick; Canada.
Introduction: There is much debate regarding the potential hazardous outcomes of canoeing on the ability of males to produce sperm. A study by F. Essaitch et al.¹ showed a reduced sperm count in males who canoe greater than or equal to 3 times per week. However, H. Too-Oh and his colleagues at a University in China have shown that the consumption of river water has lead to a decrease in the number of viable sperm in the semen. We hypothesized that this decrease in the sperm count that was observed in active paddlers was due primarily to the consumption of river water and not due to the canoeing itself. We also hypothesized that the stern paddler would exhibit this effect much more dramatically due to splash from the lazy bow paddler’s paddle.
Methods: We recruited 50 bow paddlers who were notorious for being lazy, and 50 stern paddlers all aged 25 to 26. These two groups were randomly paired up and further divided into 2 groups of 25 boats (two people per boat). In one of these groups, the paddlers wore masks that prevented intake of river water and the other group wore normal attire. All participants were required to wear loose-fitting shorts and underwear to prevent confounding variables (every effort was made to maintain an optimal environment for “the boys”) and to be shirtless (in order to try to impress local women). Every participant’s sperm was analyzed prior to initiation of the study. Groups were sent on a 20 km canoe excursion on the South Saskatchewan River 3 times per week.
Results: Overall, the participants in the group that wore masks while canoeing had a significantly higher sperm count than the group that did not wear masks. In addition, in the maskless group, the bow paddler had a much higher sperm count than the stern paddler.
Conclusions: This study suggests that the decrease in sperm production seen in active paddlers is due to consumption of river water and not due to the actual act of canoeing. It seems that the water in the South Saskatchewan River contains a substance that negatively affects sperm production. Therefore, when canoeing on the river, it is crucial that stern paddlers ensure that they have a very competent bow paddler.
Supported by the Canadian Council on Canoe Craziness (C4)
¹ Essaitch AR, Oldboatman OA, Piebald RA. 2006. Fertil Steril 173:335-43. ²Too-Oh H, Drink T, Cold V et al, 2002. J Water Temp Biol Effects. 11:21-6